Thrivent Financial for Lutherans’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$647K Buy
2025
Q1
Sell
2024
Q4
$1.2M Sell
2024
Q3
$1.7M Hold
2024
Q2
$1.68M Buy